Reweighting Randomized Controlled Trial Evidence to Better Reflect Real Life – A Case Study of the Innovative Medicines Initiative

Evidence from randomized controlled trials available for timely health technology assessments of new pharmacological treatments and regulatory decision making may not be generalizable to local patient populations, often resulting in decisions being made under uncertainty. In recent years, several re...

Descripción completa

Detalles Bibliográficos
Autores principales: Happich, Michael, Brnabic, Alan, Faries, Douglas, Abrams, Keith, Winfree, Katherine B., Girvan, Allicia, Jonsson, Pall, Johnston, Joseph, Belger, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540324/
https://www.ncbi.nlm.nih.gov/pubmed/32301116
http://dx.doi.org/10.1002/cpt.1854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540324/
https://www.ncbi.nlm.nih.gov/pubmed/32301116
http://dx.doi.org/10.1002/cpt.1854

Ejemplares similares